Introduction: A single entry point for the elderly is important for the integration of services and for standardizing needs assessment processes. The role of a single entry point role is to refer older persons to the appropriate social and/or health services. The purpose of this paper is to describe the relationships between institutional partners and their use of the single entry point in a gerontological network.

Methods: The gerontological network "Ancrage" is one of the first integrated care models with a single entry point to be implemented in France. The contact assessment tool known as CHIP (Community Hospital Intake Profile) is used to assess the needs of elderly people living at home and to make referrals. The data collected included all the requests made by partners at the single entry point over the course of one year (2008).

Results: A total of 303 requests were submitted to the single entry point by all partners (i.e. health and social professionals). These requests came from primary care professionals (68.3%), notably family physicians (29.3%). The needs of elderly people varied according to the type of requester. Most of those involved were directed toward the gerontological network (59.2%) and had more complex needs (no support from an informal caregiver and more difficulties in performing daily activities).

Conclusion: A single entry point is designed to involve all institutional partners and to meet the needs of the elderly. The level of involvement among physicians is high, and elderly people directed toward the gerontological network have the most complex clinical needs.

Download full-text PDF

Source

Publication Analysis

Top Keywords

entry point
32
single entry
28
gerontological network
16
elderly people
12
point
8
point gerontological
8
institutional partners
8
partners single
8
directed gerontological
8
single
7

Similar Publications

Objectives: Despite being a frequent entry point of care, it remains unknown if families' needs are being met across pediatric emergency departments (PEDs). Study objectives were to describe caregivers' perceived overall PED experience and needs and to what extent these needs were met.

Methods: This descriptive, cross-sectional survey with medical record review was conducted in 10 Canadian PEDs.

View Article and Find Full Text PDF

As mental health needs rise, creative and timely solutions are essential. Leveraging the expansion and flexibility of virtual services to create telehealth and hybrid offerings is crucial for addressing systemic barriers in mental health, enhancing accessibility, and providing flexible, comprehensive care options for diverse patient populations. This article discusses the development of a mental health urgent care program within a large medical system in a densely populated, under-resourced community.

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

Eisai Inc., Nutley, NJ, USA.

Background: Timely identification of mild cognitive impairment (MCI) is key to early intervention. While primary care providers are the most likely entry point to detect early signs of MCI, their detection rates are low. Building upon a published study, we used electronic health records (EHR) to develop a clinically enhanced MCI risk prediction algorithm.

View Article and Find Full Text PDF

The blood-brain barrier (BBB) consists of a unique system of brain microvascular endothelial cells, capillary basement membranes, and terminal branches ("end-feet") of astrocytes. The BBB's primary function is to protect the central nervous system from potentially harmful or toxic substances in the bloodstream by selectively controlling the entry of cells and molecules, including nutrients and immune system components. During neuroinflammation, the BBB loses its integrity, resulting in increased permeability, mostly due to the activity of inflammatory cytokines.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Dementia Research Centre, UCL Queen Square Institute of Neurology, London, United Kingdom.

The recent positive phase 3 clinical trials of new treatments and their licensing and roll-out in the US and other countries represents a major turning point in Alzheimer's disease research. As has been the case with many other diseases, e.g.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!